Alan J. Gelenberg
#161,593
Most Influential Person Now
Alan J. Gelenberg's AcademicInfluence.com Rankings
Download Badge
Biology
Alan J. Gelenberg's Degrees
- Doctorate Medicine University of Pennsylvania
Why Is Alan J. Gelenberg Influential?
(Suggest an Edit or Addition)Alan J. Gelenberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. (2000) (1452)
- A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (2000) (1290)
- The Arizona Sexual Experience Scale (ASEX): reliability and validity. (2000) (821)
- Gender differences in treatment response to sertraline versus imipramine in chronic depression. (2000) (634)
- Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006) (593)
- Gender differences in chronic major and double depression. (2000) (417)
- Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. (2012) (412)
- Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. (1989) (400)
- Effectiveness of St John's wort in major depression: a randomized controlled trial. (2001) (370)
- Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. (2000) (280)
- Pharmacologic treatment of depression during pregnancy. (1999) (255)
- Risk-benefit decision making for treatment of depression during pregnancy. (2000) (247)
- Lost human capital from early-onset chronic depression. (2000) (226)
- THE CATATONIC SYNDROME (1976) (214)
- Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. (2006) (206)
- Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depression (2006) (195)
- Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. (1998) (192)
- Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. (2008) (192)
- Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. (2009) (188)
- Catatonic reactions to high-potency neuroleptic drugs. (1977) (182)
- Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. (1992) (181)
- Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. (1993) (179)
- The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. (1998) (169)
- Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. (2003) (155)
- Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. (2005) (148)
- Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. (2002) (138)
- Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients (2005) (132)
- Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. (1982) (131)
- Mirtazapine substitution in SSRI-induced sexual dysfunction. (2000) (120)
- Tryptophan depletion and depressive vulnerability (1999) (111)
- Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. (2004) (110)
- Pindolol augmentation of treatment-resistant depressed patients. (1997) (110)
- The prevalence and impact of depression. (2010) (110)
- Antipsychotics in bipolar disorder. (1996) (109)
- Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. (1989) (107)
- How fast are antidepressants? (2000) (106)
- A review of the current guidelines for depression treatment. (2010) (105)
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. (2007) (92)
- A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. (1988) (89)
- Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. (2009) (89)
- Prevalence of tardive dyskinesia in an outpatient population. (1980) (89)
- Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. (1995) (84)
- Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. (2001) (83)
- Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. (2001) (81)
- The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. (2008) (80)
- Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology. (2010) (78)
- Lecithin can suppress tardive dyskinesia. (1978) (75)
- Randomized, Placebo-Controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression (2003) (75)
- Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. (2008) (74)
- Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression. (2002) (74)
- The Practitioner’s Guide to Psychoactive Drugs (1997) (72)
- Alternatives to lithium for preventive treatment of bipolar disorder. (1989) (70)
- Metabolic effects of treatment with atypical antipsychotics. (2004) (69)
- International consensus statement on major depressive disorder. (2010) (67)
- Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. (2000) (66)
- Tyrosine for depression: a double-blind trial. (1990) (65)
- A review of 32 cases of tardive dystonia. (1991) (64)
- Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. (2002) (63)
- Sertraline versus imipramine to prevent relapse in chronic depression. (2001) (63)
- Hazards and adverse effects of lithium. (1982) (63)
- Neurotransmitter precursors for the treatment of depression. (1982) (63)
- The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. (1998) (62)
- The meaning of serum lithium levels in maintenance therapy of mood disorders: a review of the literature. (1989) (60)
- Serum lithium levels and psychosocial function in patients with bipolar I disorder. (1996) (60)
- Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. (1979) (60)
- Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition (2005) (59)
- The pharmacologic treatment of schizophrenia: a progress report. (1983) (58)
- Amoxapine — An Antidepressant With Some Neuroleptic Properties?: A Review of Its Chemistry, Animal Pharmacology and Toxicology, Human Pharmacology, and Clinical Efficacy (1981) (57)
- Gender differences, clinical correlates, and longitudinal outcome of bipolar disorder with comorbid migraine. (2014) (57)
- Hats Off to the Reviewers!: (Editorial) (1998) (56)
- Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. (2008) (56)
- Bipolar disorder in women: reproductive events and treatment considerations (2005) (55)
- If not now, when? (1992) (54)
- The effect of dantrolene sodium on spasticity in multiple sclerosis (1973) (54)
- Citalopram as adjunctive therapy in bipolar depression. (2001) (52)
- Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice. (2010) (51)
- An open trial of Omega-3 fatty acids for depression in pregnancy* (2006) (50)
- Many Thanks: (Editorial) (2001) (50)
- Lithium tremor. (1995) (50)
- Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. (2007) (50)
- Tyrosine for the treatment of depression. (1980) (49)
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases (2007) (48)
- Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment. (2000) (44)
- Anticholinergic Effects on Memory: Benztropine versus Amantadine (1989) (43)
- Assessing and treating depression in primary care medicine. (2007) (43)
- Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. (1984) (43)
- Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: results from single lumbar puncture sampling technique. (2000) (41)
- Verapamil treatment of acute mania. (1986) (40)
- Sexual dysfunction secondary to depressive disorders. (1999) (39)
- Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. (2002) (39)
- Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. (2010) (38)
- Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study. (1980) (36)
- Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies. (2016) (35)
- Sleep quality during euthymia in bipolar disorder: the role of clinical features, personality traits, and stressful life events (2013) (35)
- Tyrosine for depression. (1982) (35)
- The effect of amoxapine and imipramine on serum prolactin levels. (1981) (34)
- Single case study. Amoxapine, a new antidepressant, appears in human milk. (1979) (33)
- Galactorrhea and hyperprolactinemia associated with amoxapine therapy. Report of a case. (1979) (31)
- Assessment of Sexual Dysfunction Using the Arizona Sexual Experiences Scale (ASEX) and Implications for the Treatment of Depression (1999) (31)
- Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients (1992) (31)
- Mediators of sexual functioning and marital quality in chronically depressed adults with and without a history of childhood sexual abuse. (2015) (30)
- Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. (2009) (28)
- Alpha2-adrenergic receptors in platelet membranes of depressed patients: Increased affinity for 3H-yohimbine (1987) (27)
- Rate-sensitive inhibition of ACTH release in depression. (1984) (27)
- Health outcomes for people with serious mental illness: a case study. (2008) (27)
- Effects of mental health benefits legislation: a community guide systematic review. (2015) (26)
- The Practitioner’s Guide to Psychoactive Drugs (1991) (25)
- Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. (1979) (24)
- Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega‐3 plasma concentrations are altered by treatment (2015) (24)
- Matching the Bipolar Patient and the Mood Stabilizer (2003) (24)
- Report on efficacy of treatments for bipolar disorder. (1993) (24)
- Depression is still underrecognized and undertreated. (1999) (23)
- DILTIAZEM FOR TARDIVE DYSKINESIA AND TARDIVE DYSTONIA (1988) (23)
- Sexual side effects of antidepressant drugs (2000) (21)
- Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study. (2009) (21)
- Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study. (2011) (20)
- Depression symptomatology and neurobiology. (2010) (19)
- Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study (2013) (19)
- Threats and promises. (1995) (19)
- Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. (1979) (19)
- Boosting serotonin in the brain: is it time to revamp the treatment of depression? (2012) (19)
- Smoking cessation in patients with psychiatric disorders. (2008) (18)
- A crossover study of lecithin treatment of tardive dyskinesia. (1990) (18)
- Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study (1984) (18)
- The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. (2004) (17)
- REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design. (2008) (17)
- Knowing our limits (1998) (17)
- Criteria for the diagnosis of catatonia. (1977) (16)
- Dr. Gelenberg and Associates Reply (1979) (16)
- Letter: Grams of antipsychotics? (1976) (16)
- Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. (2003) (16)
- Treating extrapyramidal reactions: some current issues. (1987) (15)
- Direct comparison of the psychometric properties of multiple interview and patient-rated assessments of suicidal ideation and behavior in an adult psychiatric inpatient sample. (2015) (15)
- Anticholinergic effects on memory: benztropine vs. amantadine. (1987) (15)
- Enhancement of ECT benefit by yohimbine. (1986) (15)
- Smoking cessation in patients with psychiatric disorders. (2007) (15)
- Recurrent Unipolar Depressions with a 48-hour Cycle: Report of a Case (1978) (15)
- CDP-choline for the treatment of tardive dyskinesia: a small negative series. (1989) (15)
- An open trial of maprotiline for the treatment of cocaine abuse: a pilot study. (1988) (14)
- Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized? (1989) (14)
- The state of knowledge of chronic depression. (2006) (14)
- Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction (2007) (14)
- Consent and liability with neuroleptics: the problem of tardive dyskinesia. (1986) (13)
- Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. (2003) (12)
- Ergoloid mesylates and ECT. (1989) (12)
- Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo. (1990) (12)
- Renal function monitoring in patients receiving lithium carbonate. (1981) (12)
- The effectiveness of generic agents in psychopharmacologic treatment. (2005) (11)
- A Double‐Blind Comparison of Clovoxamine and Amitriptyline in the Treatment of Depressed Outpatients (1985) (11)
- Alpha2-adrenergic receptor sensitivity in depressed patients: Relation between 3H-yohimbine binding to platelet membranes and clonidine-induced hypotension (1989) (11)
- Computerized tomography in patients with tardive dyskinesia. (1976) (11)
- Consultative intervention to improve outcomes of high utilizers in a public mental health system. (2004) (11)
- Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture. (2016) (10)
- Using physostigmine safely. (1979) (10)
- Can lithium help to prevent suicide? (2001) (10)
- More on Neuromuscular Side Effects of Antipsychotics (1976) (10)
- New Year's Thanks: (Editorial) (2007) (10)
- The Arizona Sexual Experience Scale (ASEX) (2000) (9)
- TREATMENT STRATEGIES FOR DEPRESSION AND SEXUAL DYSFUNCTION (1999) (9)
- 345. Mirtazapine substitution in SSRI-induced sexual dysfunction (1998) (9)
- Treatment of bipolar disorder: how far have we come? (1994) (8)
- The effects of amitriptyline and lithium on a patient with 48-hour recurrent depressions. (1978) (8)
- Introduction: The Practice of Pharmacotherapy (1983) (7)
- Standing Guard: (Editorial) (1996) (7)
- The American Psychiatric Association Treatment Guideline for Major Depressive Disorder: process and content (2010) (7)
- Fluoxetine and sexual dysfunction. (1995) (7)
- General Principles of Treatment of Extrapyramidal Syndromes (1983) (7)
- Choline and lecithin administration to patients with tardive dyskinesia. (1978) (7)
- 346. Sequential catecholamine and 5-HT depletion in mirtazapine-treated depressives (1998) (6)
- Use of choline and lecithin in the treatment of tardive dyskinesia. (1980) (6)
- 86-7 Double-blind crossover antidepressant study: Sertraline vs. imipramine (1997) (6)
- The amobarbital interview. (1980) (6)
- Biological therapies in psychiatry newsletter (1989) (6)
- Amoxapine for the Treatment of Psychotically Depressed Subjects: A Pilot Study (1985) (6)
- L-TYROSINE IN DEPRESSION (1980) (6)
- Pregnancy, psychotropic drugs, and psychiatric disorders. (1986) (6)
- Munchausen's syndrome with a psychiatric presentation. (1977) (5)
- Treating the outpatient schizophrenic. (1978) (4)
- Unusual lymphocyte subset distribution in some depressed patients. (1990) (4)
- The state of knowledge of chronic depression. (2006) (4)
- Depression, depressants, and antidepressants. (1990) (4)
- Arizona Sexual Experience Scale (2016) (4)
- Happy New Year!: (Editorial) (2003) (4)
- The search for knowledge: developing the American Psychiatric Association's practice guideline for major depressive disorder. (2008) (4)
- Complementary and alternative medicine in psychiatry. (2010) (4)
- Optimizing depression treatment to increase the likelihood of remission. (2010) (3)
- The effects of the Affordable Care Act on the practice of psychiatry. (2013) (3)
- Maintenance drug therapy in long-term treatment of depression (1978) (3)
- Antidepressants in the general hospital. (1979) (2)
- Use and abuse of anticholinergic drugs in psychiatry. (1984) (2)
- Major complications of neuroleptic drug use. (1994) (2)
- Postmarketing surveillance: perspectives of a journal editor. (1993) (2)
- Staying true to mission. (2007) (2)
- The art (and blood sport) of psychopharmacology research: who has a dog in the fight? (2007) (2)
- Tryptophan and 5-HT in psychiatric illness. (1996) (2)
- Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously. (1987) (2)
- Nutrition in psychiatry: we are what we eat? (1980) (2)
- Cardiac arrhythmias after psychotropic drugs. (1977) (2)
- Reply to Letter to the Editor "Rapid Onset of Antidepressant Activity With Venlafaxine" (2002) (2)
- Lithium efficacy and adverse effects. (1988) (2)
- Pharmacologic treatment of depressive subtypes. (1988) (2)
- Honoring our evidence base. (2004) (2)
- Two-year placebo-controlled maintenance study to assess recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression (2007) (2)
- Dr. Kornstein and Colleagues Reply (2001) (2)
- CEREBRAL ATROPHY AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA (1976) (2)
- Funding, conflicts, and paradigms. (2005) (1)
- New antidepressant drugs: a clinical perspective. (1984) (1)
- Reliability and risks of generic psychopharmacologic agents. (2005) (1)
- e-Etiquette: (Editorial) (2009) (1)
- Polypharmacy in Psychiatry (1995) (1)
- Dr. Karasu and Colleagues Reply (1994) (1)
- Tardive dyskinesia and lithium-associated nephropathy: are you liable? (1980) (1)
- P.2.a.016 Prevalence and clinical correlates of pain in patients with recurrent major depressive disorder (2007) (1)
- Thanks to JCP Peer Reviewers: (Editorial) (2008) (1)
- Disclosing Bias: The Author Responds (2008) (1)
- Closing remarks. The use of benzodiazepine hypnotics : a scientific examination of a clinical controversy (1992) (1)
- Iatrogenic Sexual Dysfunction (2003) (1)
- Performance improvement CME: improving outcomes in depression. (2010) (1)
- FLUOXETINE AND SEXUAL DYSFUNCTION. AUTHORS' REPLIES (1995) (1)
- Editorial Statement (2002) (1)
- Reply to Sponsored Clinical Trials and Bias (2007) (1)
- Psychiatry as a medical specialty. (1972) (1)
- Treatment of bipolar depression with citalopram (2001) (1)
- Is Religioness a Protective Factor against Suicide? Evaluating Suicidality and Religiousness in Psychiatric Inpatient Population Utilizing Sheehan Suicide Tracking Scale (S-STS) and Columbia Suicide Severity Rating Scale (C-SSRS) (2020) (1)
- Preliminary communication Omega-3 fatty acids and supportive psychotherapy for perinatal depression: A randomized placebo-controlled study (2008) (1)
- Antidepressants: their use in clinical practice. (1978) (1)
- Editors’ Thank You: (Editorial) (2015) (1)
- P.2.c.019 Two-year maintenance treatment study assessing recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression (2006) (1)
- NCDEU's golden anniversary. (2010) (1)
- The Affordable Care Act and Practice in Psychiatry (2013) (0)
- Recognizing and managing drug-induced depression (1992) (0)
- The Journal of Clinical Psychiatry: Peer Review Circle of Honor: (Editorial) (2006) (0)
- Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder (1990) (0)
- Psychiatry 2013. (1993) (0)
- Recurrence prevention in patients with recurrent major depression receiving 12 months of treatment with venlafaxine XR (2007) (0)
- Arizona Sexual Experiences Scale (ASEX) 2000 (2012) (0)
- The journal in 2004 (2004) (0)
- New Drugs, Old Dilemmas (1998) (0)
- Biography (1998) (0)
- Circle of Honor: (Editorial) (2006) (0)
- Psychotherapy in severe depression: hypothesis-generating versus hypothesis-testing. (1979) (0)
- Editor's note (2000) (0)
- Commentary 2 (0)
- Choline and lecithin for the treatment of tardive dyskinesia [proceedings]. (1979) (0)
- 90-109 Predictors of response to long-term antidepressant therapy (1997) (0)
- Another Year Passes: (Editorial) (2005) (0)
- Imperfect drugs in an imperfect world. (1992) (0)
- Reply to Letter to the Editor "Manufacturer Support and Outcome" (1999) (0)
- Call for Papers From Early Career Psychiatrists: (Editorial) (2007) (0)
- Overview of Drug Treatment (1990) (0)
- Warning: Side Effects May Include Distorted Vision (2008) (0)
- Out of the Box (2007) (0)
- Apologies and Thanks to Reviewers (1998) (0)
- Looking Ahead (2007) (0)
- New year's greetings and gratitude. (2016) (0)
- OUTCOMES OF TREATING DEPRESSION IN PREGNANCY (1999) (0)
- Postpsychotic Depression-Reply (1983) (0)
- Response to Marcus et al. Letter (2011) (0)
- Thank You to Our Peer Reviewers. (2017) (0)
- Tooting Our Horn: (Editorial) (2006) (0)
- Conceptual Approach and Analytic Framework (2015) (0)
- Ask the Expert: Psychopharmacology (2014) (0)
- Psychiatry in the 1990s. (1991) (0)
- All Good Things…. (2017) (0)
- Erratum to: The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases (2012) (0)
- JCP's circle of honor and peer reviewers. (2009) (0)
- Annual Gratitude: (Editorial) (1999) (0)
- Counterpoint : psychopharmacology supervision. (1996) (0)
- Commentary: Grow the Market (2001) (0)
- Conclusion on convulsions. (1985) (0)
- Twenty Years at the Helm: (Editorial) (2007) (0)
- Generalized anxiety disorder: an evolving concept at the border of anxiety and depression (2006) (0)
- Peer review perspective for early career psychiatrists. (2009) (0)
- Dr. Cole and Associates Reply (1992) (0)
- Mood Disorders 2002: (492442004-001) (2002) (0)
- Commentaries: Commentary 2 (1987) (0)
- Editorial statement (1995) (0)
- Clinical update: biological psychiatry. Conclusions on convulsions (1985) (0)
- Recognition and Treatment of Depression by the Primary Care Practitioner (2020) (0)
- Emergency Presentations Related to Psychiatric Medication (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alan J. Gelenberg?
Alan J. Gelenberg is affiliated with the following schools:
